Eye Health Supplement

Preservision Lutein

32 adverse event reports submitted to the FDA · 2009–2023 · Data current as of June 3, 2026

These are reports submitted to the FDA. A report does not mean the product caused the effect. Counts reflect reporting activity, not how common an effect is.

Most Reported Reactions

Top 10 reactions from 32 reports. One report may include multiple reactions — reaction totals may exceed the report count.

Blood pressure increased

Macular degeneration

Blindness

Choking

Visual impairment

Dysphagia

Dyspnoea

Foreign Body Trauma

Pruritus

Cerebrovascular Accident

Reported Outcomes

Outcome categories as recorded in FDA reports. One report may include multiple outcomes.

Outcome	Reports
Other Serious or Important Medical Event	25
Hospitalization	6
Life Threatening	3
Visited Emergency Room	2
Other Serious Outcome	1
Disability	1
Visited a Health Care Provider	1
Required Intervention	1

Who Reported

Reporter demographics where available. Many reports do not include age or gender data.

Age

Under 18

18–34

35–49

50–64

65–79

80+

Unknown

29 reports had age data; 3 unknown.

Gender

Female

Male

Unknown/Not Reported

Reports by Year

Annual report counts from 2009–2023. Spike years may reflect recalls, media coverage, or litigation rather than changes in the product.

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

Hover bars for exact counts.

← View all PreserVision products in FDA data

Data Source

This page presents data from the FDA's CFSAN Adverse Event Reporting System (CAERS) via the openFDA API. Reports are voluntary and unverified. The FDA has not concluded that this product caused any reported event.

View openFDA CAERS data ↗ · About our methodology · How to read this data